{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T01:09:02Z","timestamp":1782436142601,"version":"3.54.5"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.antiviral.2015.05.006","type":"journal-article","created":{"date-parts":[[2015,5,26]],"date-time":"2015-05-26T21:14:58Z","timestamp":1432674898000},"page":"89-100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Peptidomimetic furin inhibitor MI-701 in combination with oseltamivir and ribavirin efficiently blocks propagation of highly pathogenic avian influenza viruses and delays high level oseltamivir resistance in MDCK cells"],"prefix":"10.1016","volume":"120","author":[{"given":"Yinghui","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kornelia","family":"Hardes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven O.","family":"Dahms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"B\u00f6ttcher-Friebertsh\u00e4user","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Steinmetzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel E.","family":"Than","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Dieter","family":"Klenk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Garten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2015.05.006_b0005","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/1479-5876-9-115","article-title":"Combination therapy: the next opportunity and challenge of medicine","volume":"9","author":"Ascierto","year":"2011","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.antiviral.2015.05.006_b0010","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.2174\/092986710791331040","article-title":"Blockade of furin activity and furin-induced tumor cells malignant phenotypes by the chemically synthesized human furin prodomain","volume":"17","author":"Basak","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.antiviral.2015.05.006_b0015","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.virusres.2013.05.006","article-title":"H5N1 vaccines in humans","volume":"178","author":"Baz","year":"2013","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2015.05.006_b0020","doi-asserted-by":"crossref","first-page":"4695","DOI":"10.1016\/j.bmcl.2011.06.091","article-title":"New substrate analogue furin inhibitors derived from 4-amidinobenzylamide","volume":"21","author":"Becker","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.antiviral.2015.05.006_b0025","doi-asserted-by":"crossref","first-page":"21992","DOI":"10.1074\/jbc.M111.332643","article-title":"Highly potent inhibitors of proprotein convertase furin as potential drugs for treatment of infectious diseases","volume":"287","author":"Becker","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2015.05.006_b0030","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1021\/jm9012455","article-title":"Potent inhibitors of furin and furin-like proprotein convertases containing decarboxylated P1 arginine mimetics","volume":"53","author":"Becker","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2015.05.006_b0035","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.antiviral.2008.01.003","article-title":"Current and future antiviral therapy of severe seasonal and avian influenza","volume":"78","author":"Beigel","year":"2008","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2015.05.006_b0040","doi-asserted-by":"crossref","first-page":"5605","DOI":"10.1128\/JVI.00140-10","article-title":"Cleavage of influenza virus hemagglutinin by airway proteases TMPRSS2 and HAT differs in subcellular localization and susceptibility to protease inhibitors","volume":"84","author":"B\u00f6ttcher-Friebertsh\u00e4user","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.05.006_b0045","first-page":"3","article-title":"The hemagglutinin: a determinant of pathogenicity","volume":"385","author":"B\u00f6ttcher-Friebertsh\u00e4user","year":"2014","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.antiviral.2015.05.006_b0050","first-page":"3","article-title":"The hemagglutinin: a determinant of pathogenicity","volume":"385","author":"B\u00f6ttcher-Friebertsh\u00e4user","year":"2014","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.antiviral.2015.05.006_b0055","doi-asserted-by":"crossref","first-page":"7374","DOI":"10.1016\/j.vaccine.2012.10.001","article-title":"Hemagglutinin activating host cell proteases provide promising drug targets for the treatment of influenza A and B virus infections","volume":"30","author":"B\u00f6ttcher-Friebertsh\u00e4user","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2015.05.006_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2007.12.007","article-title":"Highly pathogenic RNA viral infections: challenges for antiviral research","volume":"78","author":"Bray","year":"2008","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2015.05.006_b0065","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1038\/nprot.2007.406","article-title":"Version 1.2 of the Crystallography and NMR system","volume":"2","author":"Br\u00fcnger","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.antiviral.2015.05.006_b0070","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10540-007-9057-9","article-title":"Animal and human health implications of avian influenza infections","volume":"27","author":"Capua","year":"2007","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.antiviral.2015.05.006_b0075","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1086\/504723","article-title":"Distribution of amantadine-resistant H5N1 avian influenza variants in Asia","volume":"193","author":"Cheung","year":"2006","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2015.05.006_b0080","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1021\/cb500087x","article-title":"X-ray structures of human furin in complex with competitive inhibitors","volume":"9","author":"Dahms","year":"2014","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.antiviral.2015.05.006_b0085","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.bcp.2013.09.010","article-title":"Dancing with chemical formulae of antivirals: a panoramic view (Part 2)","volume":"86","author":"De Clercq","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.antiviral.2015.05.006_b0090","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.tips.2007.04.005","article-title":"Avian influenza A (H5N1) infection: targets and strategies for chemotherapeutic intervention","volume":"28","author":"De Clercq","year":"2007","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.antiviral.2015.05.006_b0095","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1056\/NEJMoa054512","article-title":"Oseltamivir resistance during treatment of influenza A (H5N1) infection","volume":"353","author":"de Jong","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2015.05.006_b0100","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1134\/S1607672914020100","article-title":"The combination of ribavirin and ozeltamivir effectively inhibits reproduction of influenza A virus resistant to rimantadine (amantadine) in vitro and in vivo","volume":"455","author":"Deryabin","year":"2014","journal-title":"Dokl. Biochem. Biophys."},{"key":"10.1016\/j.antiviral.2015.05.006_b0105","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S1473-3099(14)70821-7","article-title":"Antiviral combinations for severe influenza","volume":"14","author":"Dunning","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.antiviral.2015.05.006_b0110","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of Coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallogr. Sect. D: Biol. Crystallogr."},{"key":"10.1016\/j.antiviral.2015.05.006_b0115","doi-asserted-by":"crossref","first-page":"g3308","DOI":"10.1136\/bmj.g3308","article-title":"Antiviral treatment of hepatitis C","volume":"348","author":"Feeney","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.antiviral.2015.05.006_b0120","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1021\/jm400633d","article-title":"Optimization of furin inhibitors to protect against the activation of influenza hemagglutinin H5 and Shiga toxin","volume":"57","author":"Gagnon","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2015.05.006_b0125","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/S0140-6736(08)60627-3","article-title":"Human infection with highly pathogenic H5N1 influenza virus","volume":"371","author":"Gambotto","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2015.05.006_b0130","doi-asserted-by":"crossref","first-page":"10817","DOI":"10.1074\/jbc.270.18.10817","article-title":"Furin-induced cleavage and activation of Shiga toxin","volume":"270","author":"Garred","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2015.05.006_b0135","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0300-9084(94)90149-X","article-title":"Processing of viral glycoproteins by the subtilisin-like endoprotease furin and its inhibition by specific peptidylchloroalkylketones","volume":"76","author":"Garten","year":"1994","journal-title":"Biochimie"},{"key":"10.1016\/j.antiviral.2015.05.006_b0140","series-title":"Avian Influenza","first-page":"156","article-title":"Cleavage activation of the influenza virus hemagglutinin and its role in pathogenesis","author":"Garten","year":"2008"},{"key":"10.1016\/j.antiviral.2015.05.006_b0145","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1128\/IAI.63.1.82-87.1995","article-title":"Proteolytic activation of bacterial toxins by eukaryotic cells is performed by furin and by additional cellular proteases","volume":"63","author":"Gordon","year":"1995","journal-title":"Infect. Immun."},{"key":"10.1016\/j.antiviral.2015.05.006_b0150","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/360358a0","article-title":"Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gp160","volume":"360","author":"Hallenberger","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2015.05.006_b0155","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1128\/JVI.68.5.3120-3128.1994","article-title":"Reverse genetics provides direct evidence for a correlation of hemagglutinin cleavability and virulence of an avian influenza A virus","volume":"68","author":"Horimoto","year":"1994","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.05.006_b0160","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.antiviral.2013.03.019","article-title":"Adjunctive therapies and immunomodulatory agents in the management of severe influenza","volume":"98","author":"Hui","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2015.05.006_b0165","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.coviro.2014.04.009","article-title":"The epidemiology and spread of drug resistant human influenza viruses","volume":"8","author":"Hurt","year":"2014","journal-title":"Current opinion in virology"},{"key":"10.1016\/j.antiviral.2015.05.006_b0170","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.antiviral.2006.01.012","article-title":"Combination chemotherapy, a potential strategy for reducing the emergence of drug-resistant influenza A variants","volume":"70","author":"Ilyushina","year":"2006","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2015.05.006_b0175","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nature10831","article-title":"Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA\/H1N1 virus in ferrets","volume":"486","author":"Imai","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2015.05.006_b0180","doi-asserted-by":"crossref","first-page":"36788","DOI":"10.1074\/jbc.M400484200","article-title":"Inhibition of furin by polyarginine-containing peptides: nanomolar inhibition by nona-d-arginine","volume":"279","author":"Kacprzak","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2015.05.006_b0185","series-title":"Cellular Receptors for Animal Viruses. Monograph 28","first-page":"241","article-title":"Activation cleavage of viral spike proteins","author":"Klenk","year":"1994"},{"key":"10.1016\/j.antiviral.2015.05.006_b0190","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/0042-6822(75)90284-6","article-title":"Activation of influenza A viruses by trypsin treatment","volume":"68","author":"Klenk","year":"1975","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2015.05.006_b0195","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1128\/JVI.03004-13","article-title":"Assessment of influenza virus hemagglutinin stalk-based immunity in ferrets","volume":"88","author":"Krammer","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.05.006_b0200","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.cell.2014.02.040","article-title":"Identification, characterization, and natural selection of mutations driving airborne transmission of A\/H5N1 virus","volume":"157","author":"Linster","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2015.05.006_b0205","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1038\/aps.2013.121","article-title":"Characteristics of human infection with avian influenza viruses and development of new antiviral agents","volume":"34","author":"Liu","year":"2013","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.antiviral.2015.05.006_b0210","doi-asserted-by":"crossref","first-page":"318","DOI":"10.2174\/187152607783018736","article-title":"Influenza virus transmission: basic science and implications for the use of antiviral drugs during a pandemic","volume":"7","author":"Lowen","year":"2007","journal-title":"Infect. Disord. Drug Targets"},{"key":"10.1016\/j.antiviral.2015.05.006_b0215","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.ijmm.2014.08.016","article-title":"Influenza, a One Health paradigm \u2013 novel therapeutic strategies to fight a zoonotic pathogen with pandemic potential","volume":"304","author":"Ludwig","year":"2014","journal-title":"Int. J. Med. Microbiol."},{"key":"10.1016\/j.antiviral.2015.05.006_b0220","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.cimid.2008.01.004","article-title":"The history of avian influenza","volume":"32","author":"Lupiani","year":"2009","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"10.1016\/j.antiviral.2015.05.006_b0225","doi-asserted-by":"crossref","first-page":"e71401","DOI":"10.1371\/journal.pone.0071401","article-title":"Determination of neuraminidase kinetic constants using whole influenza virus preparations and correction for spectroscopic interference by a fluorogenic substrate","volume":"8","author":"Marathe","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2015.05.006_b0230","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1743-422X-3-63","article-title":"New low-viscosity overlay medium for viral plaque assays","volume":"3","author":"Matrosovich","year":"2006","journal-title":"Virol. J."},{"key":"10.1016\/j.antiviral.2015.05.006_b0235","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.antiviral.2015.05.006_b0240","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1128\/AAC.00476-09","article-title":"Triple combination of oseltamivir, amantadine, and ribavirin displays synergistic activity against multiple influenza virus strains in vitro","volume":"53","author":"Nguyen","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2015.05.006_b0245","doi-asserted-by":"crossref","first-page":"e31006","DOI":"10.1371\/journal.pone.0031006","article-title":"Efficacy of combined therapy with amantadine, oseltamivir, and ribavirin in vivo against susceptible and amantadine-resistant influenza A viruses","volume":"7","author":"Nguyen","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2015.05.006_b0250","doi-asserted-by":"crossref","first-page":"21899","DOI":"10.1074\/jbc.M802444200","article-title":"Inhibition of Chikungunya virus infection in cultured human muscle cells by furin inhibitors: impairment of the maturation of the E2 surface glycoprotein","volume":"283","author":"Ozden","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2015.05.006_b0255","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.antiviral.2013.04.013","article-title":"Viral envelope glycoprotein processing by proprotein convertases","volume":"99","author":"Pasquato","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2015.05.006_b0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virusres.2013.11.001","article-title":"H5N1, a wealth of knowledge to improve pandemic preparedness","volume":"178","author":"Perez","year":"2013","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2015.05.006_b0265","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.coviro.2012.02.011","article-title":"Degrees of maturity: the complex structure and biology of flaviviruses","volume":"2","author":"Pierson","year":"2012","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.antiviral.2015.05.006_b0270","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1128\/AAC.00976-10","article-title":"Combinatorial approaches to the prevention and treatment of HIV-1 infection","volume":"55","author":"Pirrone","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2015.05.006_b0275","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.antiviral.2013.04.008","article-title":"Development of cellular signaling pathway inhibitors as new antivirals against influenza","volume":"98","author":"Planz","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2015.05.006_b0280","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0003-2697(79)90362-2","article-title":"Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-d-N-acetylneuraminate) substrate","volume":"94","author":"Potier","year":"1979","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.antiviral.2015.05.006_b0285","doi-asserted-by":"crossref","first-page":"e5672","DOI":"10.1371\/journal.pone.0005672","article-title":"Combination therapy using chimeric monoclonal antibodies protects mice from lethal H5N1 infection and prevents formation of escape mutants","volume":"4","author":"Prabakaran","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2015.05.006_b0290","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0166-3542(90)90001-N","article-title":"A three-dimensional model to analyze drug\u2013drug interactions","volume":"14","author":"Prichard","year":"1990","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2015.05.006_b0295","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/nprot.2008.75","article-title":"Neutral red uptake assay for the estimation of cell viability\/cytotoxicity","volume":"3","author":"Repetto","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.antiviral.2015.05.006_b0300","doi-asserted-by":"crossref","first-page":"53442","DOI":"10.1074\/jbc.M407152200","article-title":"Limited redundancy of the proprotein convertase furin in mouse liver","volume":"279","author":"Roebroek","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2015.05.006_b0305","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1146\/annurev.med.050908.132031","article-title":"H5N1 Avian influenza: preventive and therapeutic strategies against a pandemic","volume":"61","author":"Sambhara","year":"2010","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.antiviral.2015.05.006_b0310","doi-asserted-by":"crossref","first-page":"7136","DOI":"10.1128\/IAI.70.12.7136-7139.2002","article-title":"The furin inhibitor hexa-d-arginine blocks the activation of Pseudomonas aeruginosa exotoxin A in vivo","volume":"70","author":"Sarac","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.antiviral.2015.05.006_b0315","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1128\/IAI.72.1.602-605.2004","article-title":"Protection against anthrax toxemia by hexa-d-arginine in vitro and in vivo","volume":"72","author":"Sarac","year":"2004","journal-title":"Infect. Immun."},{"key":"10.1016\/j.antiviral.2015.05.006_b0320","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nrd3699","article-title":"The biology and therapeutic targeting of the proprotein convertases","volume":"11","author":"Seidah","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.antiviral.2015.05.006_b0325","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3851\/IMP2475","article-title":"Combination therapy with amantadine, oseltamivir and ribavirin for influenza A infection: safety and pharmacokinetics","volume":"18","author":"Seo","year":"2013","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2015.05.006_b0330","doi-asserted-by":"crossref","first-page":"20847","DOI":"10.1074\/jbc.M703847200","article-title":"Targeting host cell furin proprotein convertases as a therapeutic strategy against bacterial toxins and viral pathogens","volume":"282","author":"Shiryaev","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2015.05.006_b0335","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1006\/viro.1998.9488","article-title":"Characterization of avian H5N1 influenza viruses from poultry in Hong Kong","volume":"252","author":"Shortridge","year":"1998","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2015.05.006_b0340","doi-asserted-by":"crossref","first-page":"4860","DOI":"10.1016\/j.bmcl.2011.06.033","article-title":"Development of substrate analogue inhibitors for the human airway trypsin-like protease HAT","volume":"21","author":"Sielaff","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.antiviral.2015.05.006_b0345","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.virusres.2013.05.009","article-title":"Natural history of highly pathogenic avian influenza H5N1","volume":"178","author":"Sonnberg","year":"2013","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2015.05.006_b0350","series-title":"Strategies for the Development of Influenza Drugs: Basis for New Efficient Combination Therapies","first-page":"1","author":"Steinmetzer","year":"2015"},{"key":"10.1016\/j.antiviral.2015.05.006_b0355","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1002\/j.1460-2075.1992.tb05305.x","article-title":"Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin-like endoprotease","volume":"11","author":"Stieneke-Gr\u00f6ber","year":"1992","journal-title":"EMBO J."},{"key":"10.1016\/j.antiviral.2015.05.006_b0360","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.antiviral.2012.03.001","article-title":"Combinations of favipiravir and peramivir for the treatment of pandemic influenza A\/California\/04\/2009 (H1N1) virus infections in mice","volume":"94","author":"Tarbet","year":"2012","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2015.05.006_b0365","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s00705-013-1922-1","article-title":"In vitro activity of favipiravir and neuraminidase inhibitor combinations against oseltamivir-sensitive and oseltamivir-resistant pandemic influenza A (H1N1) virus","volume":"159","author":"Tarbet","year":"2014","journal-title":"Arch. Virol."},{"key":"10.1016\/j.antiviral.2015.05.006_b0370","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/nrm934","article-title":"Furin at the cutting edge: from protein traffic to embryogenesis and disease","volume":"3","author":"Thomas","year":"2002","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.antiviral.2015.05.006_b0375","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1128\/JVI.68.2.1213-1218.1994","article-title":"Sequence specificity of furin, a proprotein-processing endoprotease, for the hemagglutinin of a virulent avian influenza virus","volume":"68","author":"Walker","year":"1994","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.05.006_b0380","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/nyas.12462","article-title":"Continuing challenges in influenza","volume":"1323","author":"Webster","year":"2014","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.antiviral.2015.05.006_b0385","series-title":"Avian Influenza","first-page":"11","article-title":"H5N1 in Asia","author":"Yen","year":"2008"},{"key":"10.1016\/j.antiviral.2015.05.006_b0390","unstructured":"World Health Organisation, 2015. Cumulative number of confirmed human cases of avian influenza A (H5N1) reported to WHO, Available: <http:\/\/www.who.int\/influenza\/human_animal_interface\/H5N1_cumulative_table_archives\/en\/>. Downloaded on 06.01.15."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354215001266?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354215001266?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T17:31:10Z","timestamp":1599067870000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354215001266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":78,"alternative-id":["S0166354215001266"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2015.05.006","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peptidomimetic furin inhibitor MI-701 in combination with oseltamivir and ribavirin efficiently blocks propagation of highly pathogenic avian influenza viruses and delays high level oseltamivir resistance in MDCK cells","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2015.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}